NTNU is Norway's largest university with just over 40,000 students and more than 7,000 employees.
While it was founded in 1910, it can trace its roots back to 1760 and the Royal Norwegian Science Society (DKNVS). The main seat of the University is located in Trondheim, with additional campuses in Gjøvik and Ålesund. NTNU has eight faculties as well as units such as the NTNU Science Museum and the NTNU University Library.
Pr. John de Mello
is a professor of chemistry and the director of NTNU’s strategic initiative in nanoscience and functional materials, NTNU Nano. Prior to this, he was a professor of nanomaterials in the chemistry department at Imperial College. HIs research is focused on controlled production processes for functional materials and devices, and their application in photonics, electronics and biosensors. He has published over 130 papers (H-Index 53), five book chapters and four patents. He was a co-recipient of the Royal Society's Brian Mercer Award for Innovation in Nanotechnology and is a former Royal Society Industry Fellow.
He was a co-founder of Molecular Vision Ltd. - an Imperial College spin-out company specialising in the use of organic light-emitting diodes and photodiodes for chemical sensing. Molecular Vision was acquired by Abingdon Health in 2015, winning Abingdon the UK Medtech Dealmaker of the year award in OBN’s annual life-sciences competition (see https://tinyurl.com/yyy5332m).
Main project tasks
Application of high resolution organic light-emitting diode displays and waveguide structures as external 2D light-sources for optogenetic stimulation.
Development of low resolution OLED matrices as embeddable 2D light-sources for optogenetic stimulation.